Pleasant Prairie, WI, United States of America

Albert Wayne Kruger

USPTO Granted Patents = 9 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 8.3

ph-index = 1

Company Filing History:

Abbvie Deutschland Gmbh and Co Kg

patents

1 out of 1

Enata Pharmacueticals, Inc.

patent

where one patent can have more than one assignee

Years Active: 2014-2023

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11542239 - Elagolix sodium compositions and processes (2023-01-03),

2. 9879033 - Modulators of 5-HT receptors and methods of use thereof (2018-01-30),

3. 9493506 - Macrocyclic hepatitis C serine protease inhibitors (2016-11-15),

4. 9359356 - Azaadamantane formate ester and process for preparing azaadamantane derivatives (2016-06-07),

5. 9260411 - Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile (2016-02-16),

6. 9187483 - Modulators of 5-HT receptors and methods of use thereof (2015-11-17),

7. 8969562 - Azaadamantane formate ester and process for preparing azaadamantane derivatives (2015-03-03),

8. 8846951 - Modulators of 5-HT receptors and methods of use thereof (2014-09-30),

9. 8748374 - Macrocyclic hepatitis C serine protease inhibitors (2014-06-10),

Title: The Inventive Mind of Albert Wayne Kruger

Introduction:

Albert Wayne Kruger, a prolific inventor based in Pleasant Prairie, Wisconsin, has made significant contributions to the field of pharmaceuticals with a total of 9 patents to his name. His innovative spirit and dedication to advancing medical science have led to groundbreaking discoveries in the realm of drug compositions and treatment methods.

Latest Patents:

Kruger's latest patents showcase his expertise in pharmaceutical formulations and therapeutic modalities. The patents include inventions such as Elagolix sodium compositions, which focus on the preparation of compositions of elagolix sodium, and modulators of 5-HT receptors, which involve novel compounds and processes for treating various disease conditions.

Career Highlights:

Throughout his career, Albert Wayne Kruger has been associated with prestigious companies such as AbbVie Inc. and AbbVie Deutschland GmbH & Co. KG. His tenure at these organizations has provided him with the resources and platform to bring his innovative ideas to life and contribute significantly to the pharmaceutical industry.

Collaborations:

Kruger has collaborated with esteemed professionals in the field, including coworkers such as Dennie S Welch and Jorge Gandarilla. These collaborations have facilitated the exchange of ideas, the development of new concepts, and the successful execution of groundbreaking projects in the pharmaceutical sector.

Conclusion:

Albert Wayne Kruger's journey as an inventor has been marked by a relentless pursuit of excellence, a passion for innovation, and a commitment to making a positive impact on healthcare. His patented inventions stand as a testament to his ingenuity and vision, and his collaborations with industry experts have further enriched the landscape of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.